Luxabendazole, with the CAS number 90509-02-7, is a chemical compound primarily recognized for its application as an anthelmintic agent, particularly in veterinary medicine. It belongs to the benzimidazole class of compounds, which are characterized by their broad-spectrum activity against parasitic worms. Luxabendazole exhibits a mechanism of action that involves the inhibition of microtubule formation in parasites, leading to their immobilization and eventual death. The compound is typically administered in a formulation that enhances its bioavailability and efficacy. In terms of physical properties, Luxabendazole is generally a white to off-white crystalline solid, with moderate solubility in organic solvents and limited solubility in water. Its stability under various environmental conditions makes it suitable for use in pharmaceutical formulations. Safety and toxicity profiles are essential considerations in its application, and it is subject to regulatory assessments to ensure its safe use in target animal species. Overall, Luxabendazole represents an important tool in the management of parasitic infections in veterinary practice.

Luxabendazole

90509-02-7: Luxalbendazole, methyl N-[5-(4-fluorophenyl)sulfonyloxy-3H-benzoimidazol-2-yl]carbamate, 2-[(methoxycarbonyl)amino]-1H-benzimidazol-6-yl 4-fluorobenzenesulfonate

Luxabendazole: broad-spectrum anthelmintic effective on various worm stages.

CAS 90509-02-7: Luxabendazole

Luxabendazole

Ref: 4Z-L-108001

Luxabendazole

Ref: TM-T20960

Luxabendazole

Ref: TR-L473560